How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

267,327 results for

Risk Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community

COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community NICE guideline Published: 3 April 2020 www.nice.org.uk/guidance/ng163 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived (...) -and- conditions#notice-of-rights). Page 2 of 19Contents Contents Overview 4 1 Communicating with patients and minimising risk 5 2 Treatment and care planning 6 3 General advice for managing COVID-19 symptoms 7 4 Managing cough 8 5 Managing fever 10 6 Managing breathlessness 11 7 Managing anxiety, delirium and agitation 15 8 Managing medicines for patients with COVID-19 17 9 Prescribing anticipatory medicines for patients with COVID-19 18 10 Healthcare workers 19 COVID-19 rapid guideline: managing symptoms

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

42. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

have: • symptoms lasting less than 14 days and and • good functional status and and • a life expectancy of 1 year or more and and • a low risk of bleeding. [2012] [2012] NICE has published interventional procedures guidance on ultrasound-enhanced, catheter- directed thrombolysis for deep vein thrombosis. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions (...) Venous thromboembolic diseases: diagnosis, management and thrombophilia testing Venous thromboembolic diseases: diagnosis, management and thrombophilia testing NICE guideline Published: 26 March 2020 www.nice.org.uk/guidance/ng158 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

43. Abdominal aortic aneurysm: diagnosis and management

Abdominal aortic aneurysm: diagnosis and management Abdominal aortic aneurysm: diagnosis and management NICE guideline Published: 19 March 2020 www.nice.org.uk/guidance/ng156 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising (...) Monitoring and reducing the risk of rupture 10 1.3 Emergency transfer to regional vascular services 11 1.4 Predicting and improving surgical outcomes 12 1.5 Repairing unruptured aneurysms 14 1.6 Repairing ruptured aneurysms 17 1.7 Monitoring for complications after endovascular aneurysm repair 18 1.8 Managing endoleaks after endovascular aneurysm repair 19 T erms used in this guideline 20 Recommendations for research 22 Key recommendations for research 22 Other recommendations for research 24 Rationale

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

44. An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services Full Text available with Trip Pro

An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please (...) choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services {{author}} {{($index , , , , , & . Ben Hannigan 1, * , Deborah Edwards 1 , Nicola Evans 1 , Elizabeth Gillen 2 , Mirella Longo 3 , Steven Pryjmachuk

2015 NIHR HTA programme

45. Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community

communication of negative results or otherwise as feasible. • Provide public health advice to the case and household (or co-living setting) contacts on individual measures outlined in Appendix 2. Version: March 10, 2020 5 CONTACT IDENTIFICATION AND MANAGEMENT The following table provides guidance on risk assessment of contacts and corresponding public health management. If a contact belongs to more than one risk category, the highest risk category should apply. The risk categories are not absolute and may (...) Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community Interim Guidance: Public Health Management of cases and contacts associated with novel coronavirus (COVID-19) in the community March 10, 2020 CONTEXT The British Columbia Centre for Disease Control (BCCDC) has adapted the interim guidance from the Public Health Agency of Canada (PHAC) for Regional Health Authorities (RHA) for public health management of human illness

2020 CPG Infobase

46. myCOPD for self-management of chronic obstructive pulmonary disease

myCOPD for self-management of chronic obstructive pulmonary disease myCOPD for self-management of chronic obstructive pulmonary disease Medtech innovation briefing Published: 1 April 2020 www.nice.org.uk/guidance/mib214 pathways Summary Summary • The technology technology described in this briefing is myCOPD. It helps people with chronic obstructive pulmonary disease (COPD) to manage their symptoms and reduce the number of healthcare visits they need. It also helps the healthcare professionals (...) that most people with COPD can learn correct inhaler technique if they are trained. It also recommends individualised self-management plans for people with COPD. These should include education, and an action plan for managing the risk of exacerbations. For some people with COPD (such as people who are functionally breathless or people who have recently been hospitalised because of an acute exacerbation), pulmonary rehabilitation is recommended. This helps to manage symptoms and improve exercise capacity

2020 National Institute for Health and Clinical Excellence - Advice

47. NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds

NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds Medtech innovation briefing Published: 17 March 2020 www.nice.org.uk/guidance/mib208 pathways Summary Summary • The technology technology described in this briefing is NATROX. It is used to treat chronic non-healing and complex wounds, including diabetic foot ulcers. • The innovative (...) to be disabled and is protected under the 2010 Equalities Act. NATROX is intended for use in people with non-healing wounds. Elderly people, people with heart conditions, and people with diabetes are at an increased risk of non-healing wounds and may NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds (MIB208) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 10benefit

2020 National Institute for Health and Clinical Excellence - Advice

48. Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report

Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report Journal Pre-proof Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report Anne B. Chang, PhD, John J. Oppenheimer, MD; FCCP, Richard S. Irwin, MD, Master FCCP, on behalf of the CHEST Expert Cough Panel PII: S0012-3692(20)30325-1 DOI: https://doi.org/10.1016/j.chest.2020.01.042 Reference: CHEST 2916 To appear in: CHEST (...) Received Date: 8 November 2019 Revised Date: 11 December 2019 Accepted Date: 9 January 2020 Please cite this article as: Chang AB, Oppenheimer JJ, Irwin RS, on behalf of the CHEST Expert Cough Panel, Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report, CHEST (2020), doi: https://doi.org/10.1016/j.chest.2020.01.042. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page

2020 American College of Chest Physicians

49. Gastrointestinal infections: guidance for public health management

Gastrointestinal infections: guidance for public health management Gastrointestinal infections: guidance for public health management - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Guidance Gastrointestinal infections: guidance for public health management (...) Guidance to help professionals in public health and environmental health departments to minimise the risk of transmission of gastrointestinal infections. Published 31 January 2020 From: Documents Ref: PHE publications gateway number: GW-1020 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This guidance

2020 Public Health England

50. Joint RCOG, BSGE and BGCS guidance for the management of abnormal uterine bleeding in the evolving Coronavirus (COVID-19) pandemic

the current pandemic. These are frequent symptoms that raise concerns about gynaecological cancer. It provides national guidance for contingency planning for individual health care practitioners, service managers and commissioners to mitigate the effects of reductions in human and physical resources on our service. Our objectives are: 1. To reduce the risk of person to person (horizontal) transmission of the virus SARS-CoV-2, which causes COVID-19. 2. To make the best use of very limited human (...) Joint RCOG, BSGE and BGCS guidance for the management of abnormal uterine bleeding in the evolving Coronavirus (COVID-19) pandemic Joint RCOG, BSGE and BGCS guidance for the management of abnormal uterine bleeding in the evolving Coronavirus (COVID-19) pandemic This consensus statement provides a framework for the management of women with abnormal uterine bleeding (heavy menstrual bleeding (HMB), inter-menstrual (IMB), postmenopausal bleeding (PMB) or post coital bleeding (PCB)) during

2020 Royal College of Obstetricians and Gynaecologists

51. Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care

Algorithm amended to clarify that travel includes transit through a risk area Addition of: - section on test results - section on further information Waste guidance amended to reflect management as Category B Appendix 3: Removed reference to double glove. Version history has been moved to page 1. V8.1 24/02/2020 Reference to coronavirus (2019n-CoV) changed to COVID-19 V8.2 26/02/2020 Included links to PPE instructional videos V8.3. 28/02/2020 Phone numbers corrected in appendix 2 V8.4 05/03/2020 Phone (...) or confirmed COVID-19. Staff who think they may be at increased risk should seek advice from their line manager or local Occupational Health service. Pregnant staff should also seek advice from their line manager or local Occupational Health service. Guidance on COVID-19 and pregnancy is available on the Royal College of Obstetricians and Gynaecologists website. 6.3. Face to face clinical assessment Where possible consider practical approaches to facilitate infection prevention and control measures

2020 Covid-19 Ad hoc guidelines

52. PICS Guidance on management of critically ill children with Covid-19 infection

PCC team if available) Not critically ill Liaise with PHE Sinha/Ramnarayan/Fraser v4.0 14.03.20 Confirmed cases can also be managed with full PPE and isolation as per PHE guidance. However, if the risk of aerosol generation with HFNC or NIV is considered to be high, early intubation and invasive ventilation may be necessary. Sinha/Ramnarayan/Fraser v4.0 14.03.20 Appendix 1 – PHE recommendations for Aerosol generating procedures This can be found on the PHE website – link below https://www.gov.uk (...) PICS Guidance on management of critically ill children with Covid-19 infection Sinha/Ramnarayan/Fraser v4.0 14.03.20 PAEDIATRIC CRITICAL CARE COVID-19 GUIDANCE Key points • Coronavirus (COVID-19) is an air-borne disease, characterized by its ability to spread rapidly among healthcare staff who are not properly protected. It can be difficult to rapidly diagnose and has a high case-fatality rate in adults but generally appears to be a mild illness in children. • The key considerations for all

2020 Covid-19 Ad hoc guidelines

53. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic Full Text available with Trip Pro

="/static_file/Escardio/Medias/education/covid-19/Guidance-Document/Table_04_escardio-hPhotoMedium.jpg" width="372"> The level of protection of depends on patient risk status, setting and procedure performed ( ). In addition to personal protective equipment ( ) for , all suspected/probable or confirmed patients should wear a disposable surgical mask when in room with or other persons. Table 5 SARS-CoV‑2 related personal protection management 54, 62 " class="zoomimage caption" height="286" src="/static_file (...) to be used according to type of procedures and levels of risk." class="zoomimage caption" height="524" src="/static_file/Escardio/Medias/education/covid-19/Guidance-Document/Figure_04_escardio-hPhotoMedium.jpg" width="372"> All should be well-versed in proper techniques for donning and removing including eye protection ( and ). 58 Figure 5 Guidance on donning personal protective equipment (PPE) to manage COVID-19 patients (modified from the 'Handbook of COVID-19 Prevention and Treatment'). 58 " class

2020 European Society of Cardiology

54. COVID-19 Aviation Health Safety Protocol: Guidance for the management of airline passengers in relation to the COVID-19 pandemic

of clarity, this guidance on passenger management is presented in the following sequence: at all times, before arriving at the departure airport, at the airport, on board the aircraft and at the arrival airport. As indicated, the proposed measures will be regularly evaluated and updated in line with changes in knowledge of the risk of transmission, as well as with the development of other diagnostic or preventive measures. 3.1 At all times OBJECTIVE: To ensure that passengers arriving at the airport (...) for management of crew members 17 and the EASA Interim guidance on Aircraft Cleaning and Disinfection 18 . Extra attention needs to be devoted to the prevention and treatment of unruly passengers in the context of the pressures imposed by the pandemic. This should consider multi-layered actions starting with passenger information and preparation about the measures in place, and giving attention to the procedures and crew actions necessary mitigate this risk. 3.5 Management of passengers on board with COVID

2020 European Centre for Disease Prevention and Control - Technical Guidance

55. Covid-19: Guidance for managing staff and residents with COVID-19 infection in aged residential care facilities

in an outbreak situation, most people meeting the suspect case definition will NOT have COVID-19. • Standard precautions and contact and droplet precautions should be undertaken by all staff when interacting with the resident as per the Facilities Pandemic Plan and infectious disease protocols for management of COVID-19. If the resident has probable or confirmed COVID-19, a clinical and risk assessment will need to be undertaken to establish the best place of care for the resident. • Seek medical guidance (...) Covid-19: Guidance for managing staff and residents with COVID-19 infection in aged residential care facilities COVID-19: Guidance for managing staff/residents with COVID-19 infection in aged residential care facilities 26 April 2020 This document outlines guidance on managing staff and residents with potential COVID-19 infection in aged residential care (ARC) facilities. District health boards (DHBs) are expected to work closely with ARC facilities to ensure there are adequate supplies

2020 Covid-19 Ad hoc guidelines

56. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Full Text available with Trip Pro

Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. In May 2019, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved an update to the 2013 joint clinical practice guideline for assessing and managing patients who are at risk for suicide. This guideline provides health care providers with a framework by which to screen for, evaluate (...) , treat, and manage the individual needs and preferences of VA and DoD patients who may be at risk for suicide.In January 2018, the VA/DoD Evidence-Based Practice Work Group convened to develop a joint VA/DoD guideline including clinical stakeholders and conforming to the National Academy of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel drafted key questions, systematically searched and evaluated the literature through April 2018, created algorithms, and advanced

2019 Annals of Internal Medicine

57. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer

Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer Familial breast cancer: classification, care Familial breast cancer: classification, care and managing breast cancer and related and managing breast cancer and related risks in people with a family history of risks in people with a family history of breast cancer breast cancer Clinical guideline Published: 25 June 2013 nice.org.uk/guidance/cg164 © NICE 2018 (...) NICE recommendations wherever possible. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (CG164) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 48Contents Contents Overview 4 Who is it for? 4 Recommendations 5 1.1 Clinical significance of a family history of breast cancer 5 1.2 Information and support 8 1.3 Care

2013 National Institute for Health and Clinical Excellence - Clinical Guidelines

58. Efficacy of a Home Visiting Enhancement for High-Risk Families Attending Parent Management Programs: A Randomized Superiority Clinical Trial Full Text available with Trip Pro

Efficacy of a Home Visiting Enhancement for High-Risk Families Attending Parent Management Programs: A Randomized Superiority Clinical Trial Antisocial behavior and adult criminality often have origins in childhood and are best addressed early in the child's life using evidence-based parenting programs. However, families with additional risk factors do not always make sufficient changes while attending such programs; these families may benefit from additional support.To evaluate the efficacy (...) of adding a 10-session, structured home parent support (HPS) intervention to enhance outcomes for high-risk families attending the Incredible Years Parent (IYP) program.A randomized clinical superiority trial of 126 parents of children aged 3 to 7 years with conduct problems compared the IYP program plus HPS with treatment as usual of the IYP program alone. Child behavior measures were collected before and after treatment and at the 6-month follow-up. Recruitment from 19 IYP groups began February 13

2019 EvidenceUpdates

59. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department Full Text available with Trip Pro

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department The Ottawa chronic obstructive pulmonary disease (COPD) Risk Scale (OCRS), which consists of 10 criteria, was previously derived to identify patients in the emergency department with COPD who were at high risk for short-term serious outcomes. We sought to validate, prospectively and explicitly, the OCRS when applied by physicians in the emergency (...) department.We conducted this prospective cohort study involving patients in the emergency departments at 6 tertiary care hospitals and enrolled adults with acute exacerbation of COPD from May 2011 to December 2013. Physicians evaluated patients for the OCRS criteria, which were recorded on a data form along with the total risk score. We followed patients for 30 days and the primary outcome, short-term serious outcomes, was defined as any of death, admission to monitored unit, intubation, noninvasive

2019 EvidenceUpdates

60. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Full Text available with Trip Pro

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Asthma is a common chronic airway disease worldwide. Despite its large population size, China has had no comprehensive study of the national prevalence, risk factors, and management of asthma. We therefore aimed to estimate the national prevalence of asthma in a representative sample of the Chinese population.A representative sample of 57 779 adults aged 20 years or older was recruited (...) . Asthma was determined on the basis of a self-reported history of diagnosis by a physician or by wheezing symptoms in the preceding 12 months. All participants were assessed with a standard asthma questionnaire and were classed as having or not having airflow limitation through pulmonary function tests before and after the use of a bronchodilator (400 μg of salbutamol). Risk factors for asthma were examined by multivariable-adjusted analyses done in all participants for whom data on the variables

2019 Lancet

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>